We are live on ! Find out more
OMED

OncoMed Pharmaceuticals, Inc.
OMED

Delisted

OMED was delisted on the 22nd of April, 2019.

Back to rankings

83 hedge funds and large institutions have $247M invested in OncoMed Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

85% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 20

48% more call options, than puts

Call options by funds: $3.19M | Put options by funds: $2.16M

41% more capital invested

Capital invested by funds: $175M → $247M (+$71.9M)

5% less funds holding

Funds holding: 87 → 83 (-4)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

Holders
83
Holders Change
-4
Holders Change %
-4.6%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
8
Increased
37
Reduced
20
Closed
12
Calls
$3.19M
Puts
$2.16M
Net Calls
+$1.03M
Net Calls Change
+$2.3M

Top Buyers

Rank Fund Capital Flow
1
IHM
Iguana Healthcare Management
New York
+$5.63M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$3.74M
3
ASP
Adams Street Partners
Illinois
+$3.61M
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$3.6M
5
VAM
Visium Asset Management
New York
+$3.34M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$7.88M
2
ICM
IronBridge Capital Management
Illinois
-$3.03M
3
Millennium Management
Millennium Management
New York
-$1.99M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$1.81M
5
Prudential Financial
Prudential Financial
New Jersey
-$1.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$2.04M – – –
Jennison Associates
27
Jennison Associates
New York
$2.02M +$1.83M +89,546 New
CS
28
Credit Suisse
Switzerland
$1.8M -$55.3K -2,700 -3%
NSEDCP
29
NJ State Employees Deferred Compensation Plan
New Jersey
$1.58M +$1.43M +70,000 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.46M +$7.64K +373 +0.6%
QI
31
QS Investors
New York
$1.45M -$36.1K -1,763 -3%
BIM
32
BlackRock Investment Management
Delaware
$1.33M +$9.55K +466 +0.8%
BC
33
Birchview Capital
Vermont
$1.32M – – –
TAM
34
Tocqueville Asset Management
New York
$1.29M +$438K +21,400 +60%
BAM
35
Brave Asset Management
New Jersey
$1.05M -$2.05K -100 -0.2%
HLA
36
Hamilton Lane Advisors
Pennsylvania
$1M +$8.42K +411 +0.9%
Charles Schwab
37
Charles Schwab
California
$936K +$18.6K +910 +2%
AA
38
ALPS Advisors
Colorado
$894K -$150K -7,323 -16%
PI
39
Putnam Investments
Massachusetts
$858K -$16.7K -813 -2%
Susquehanna International Group
40
Susquehanna International Group
Pennsylvania
$806K +$131K +6,375 +22%
HCM
41
Hodges Capital Management
Texas
$789K – – –
NFA
42
Nationwide Fund Advisors
Ohio
$782K +$123 +6 +0%
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$708K +$12.3K +600 +2%
Deutsche Bank
44
Deutsche Bank
Germany
$678K -$580K -28,320 -48%
GT
45
Glenmede Trust
Pennsylvania
$646K – – –
ProShare Advisors
46
ProShare Advisors
Maryland
$601K +$43.7K +2,134 +9%
TA
47
Teachers Advisors
New York
$548K – – –
PCM
48
Piermont Capital Management
Missouri
$475K -$29.5K -1,440 -6%
SO
49
STRS Ohio
Ohio
$448K – – –
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$397K – – –
1
2
3 4

OMED Hedge Fund Activity: Q4 2015 in Review

83 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in OncoMed Pharmaceuticals, Inc. (OMED) for Q4 2015, worth a combined $247M — up 41% from $175M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of OMED and 8 opened new positions — a net loss of 4 holders — while 20 trimmed existing stakes and 37 added.

The largest buyer was Iguana Healthcare Management, adding an estimated $5.63M. The largest seller was BVF Inc, cutting an estimated $7.88M.

  • 83 institutional investors held OncoMed Pharmaceuticals, Inc. (OMED) as of Q4 2015, down from 87 in Q3 2015.
  • Funds reported $247M of OncoMed Pharmaceuticals, Inc. stock for Q4 2015, up 41% quarter-over-quarter.
  • 8 funds opened new OncoMed Pharmaceuticals, Inc. positions in Q4 2015 and 12 closed out, a net change of -4 holders.
  • The largest OncoMed Pharmaceuticals, Inc. buyer in Q4 2015 was Iguana Healthcare Management, an estimated $5.63M added.
  • The largest OncoMed Pharmaceuticals, Inc. seller in Q4 2015 was BVF Inc, an estimated $7.88M sold.

Based on aggregated 13F filings for Q4 2015.